Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2010
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126082A1 Therapeutic agent for motor disorders
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125390A1 Therapeutic agents 713
11/04/2010WO2010125330A1 Use of pufas to treat nerve damage
11/04/2010WO2010125271A1 Use of n2o gas for treating chronic pain
11/04/2010WO2010125135A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125134A1 N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125103A1 Diketopiperazine derivatives as p2x7 modulators
11/04/2010WO2010125102A1 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
11/04/2010WO2010125042A1 Isoxazole derivatives
11/04/2010WO2010125033A1 Azabicyclo[4.1.0]heptane derivatives
11/04/2010WO2010124873A1 3- (2, 2, 2, trimethylhydrazunium) propionate dihydrate (meldomium) for treating parkinson' s disease
11/04/2010WO2010124857A1 Intrastriatal botulinum toxin therapy
11/04/2010WO2010124856A1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
11/04/2010WO2010124713A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
11/04/2010WO2010124695A1 Use of griseofulvin for the improvement of mental faculties: attention, concentration and memory
11/04/2010WO2010124623A1 Medicine for preventing and treating alzheimer's disease and preparative method thereof
11/04/2010WO2010124520A1 Pharmaceutical composition for treating abnormal energy metabolism and use thereof
11/04/2010WO2010124322A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010WO2010102248A3 Molecular tweezers for the treatment of amyloid-related diseases
11/04/2010WO2010095943A3 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning
11/04/2010WO2010085352A3 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280130 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
11/04/2010US20100280127 Inhibiting neurotransmitter reuptake
11/04/2010US20100280124 Acyl-urea derivatives and uses thereof
11/04/2010US20100280119 L-ornithine phenyl acetate and methods of making thereof
11/04/2010US20100280118 Methods for treating substance dependence
11/04/2010US20100280093 Process for the preparation enantiomerically pure salts of n-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine
11/04/2010US20100280092 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
11/04/2010US20100280091 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disbustituted pyran derivatives
11/04/2010US20100280087 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
11/04/2010US20100280083 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
11/04/2010US20100280082 Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280071 Benzimidazoles which have activity at m1 receptor and their uses in medicine
11/04/2010US20100280066 Acylated amino acid amidyl pyrazoles and related compounds
11/04/2010US20100280065 Perharidines as cdk inhibitors
11/04/2010US20100280060 Methods of screening and compositions for life span modulators
11/04/2010US20100280053 CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist
11/04/2010US20100280052 Use of antivirals to treat cmv-related conditions
11/04/2010US20100280051 Use of allopurinol for the treatment of hand foot skin reaction
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280047 Salts of active ingredients with polymeric counter-ions
11/04/2010US20100280039 Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280029 Novel compounds
11/04/2010US20100280027 Pharmaceutical compounds
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280023 Thiazole derivatives
11/04/2010US20100280020 Isoxazoles
11/04/2010US20100280017 Combination of Selected Analgesics and Cox-II Inhibitors
11/04/2010US20100280016 Pyrazoline compounds
11/04/2010US20100280015 Noval 1,4-diaza-biclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
11/04/2010US20100280014 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100280009 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100280002 Aminopyridine-derivatives as inductible no-synthase inhibitors
11/04/2010US20100280000 Therapeutic agents 713
11/04/2010US20100279998 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279986 Heterocyclic derived metalloprotease inhibitors
11/04/2010US20100279984 Pharmaceutical compositions containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279944 Suppression and treatment of neuropathic pain
11/04/2010US20100279943 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases
11/04/2010US20100279942 Methods for treating motor neuron disease
11/04/2010US20100279932 Binding constructs and methods for use thereof
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279327 Method of treating diseases with parp inhibitors
11/04/2010US20100278944 Application of american ginseng to enhance neurocognitive function
11/04/2010US20100278926 Controlled Release Oral Dosage Form
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278912 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
11/04/2010US20100278907 Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
11/04/2010US20100278901 Compositions and methods of making rapidly dissolving ionically masked formulations
11/04/2010US20100278899 Edible film
11/04/2010US20100278878 Quetiapine salts and their polymorphs
11/04/2010US20100278855 Neuroprotective ganoderma compositions and methods of use
11/04/2010US20100278839 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278814 Prevention and treatment of synucleinopathic and amyloidogenic disease
11/04/2010US20100278810 Methods of Modulating Angiogenesis
11/04/2010US20100278803 Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation
11/04/2010US20100278786 Use of the opposite cell differentiation program (ocdp) for the treatment of degenerated organs in the pathological state
11/04/2010US20100278743 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling
11/04/2010US20100278741 Novel compositions including sphingosine kinase type 1 inhibitors, and processes for using same
11/04/2010CA2777479A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
11/04/2010CA2762009A1 Use of pufas to treat nerve damage
1 ... 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 ... 1833